Uncovering molecular targets for childhood cancer therapeutics

In the past two decades, despite extensive efforts to identify the genes associated with 11q aberrations in NB, definitive answers are still unclear. This distinct gap in the field has spurred a team of Tokyo Medical and Dental University (TMDU)-centered researchers to investigate the role of the gene ATM and DNA damage response (DDR)-associated molecules located in 11q. A report of the results was recently published.

Read more: https://medicalxpress.com/news/2017-12-uncovering-molecular-childhood-cancer-therapeutics.html